81
Views
6
CrossRef citations to date
0
Altmetric
Expert Opinion

Armodafinil in the treatment of sleep/wake disorders

, &
Pages 417-427 | Published online: 16 Jul 2010

References

  • American Academy of Sleep MedicineInternational Classification of Sleep Disorders2nd EditionDiagnostic and Coding ManualWestchester, ILAmerican Academy of Sleep Medicine2005
  • DrakeCLRoehrsTRichardsonGWalshJKRothTShift work sleep disorder: prevalence and consequences beyond that of symptomatic day workersSleep20042781453146215683134
  • HorstmannSHessCWBassettiCGuggerMMathisJSleepiness-related accidents in sleep apnea patientsSleep200023338338910811382
  • KingshottRNCowanJOJonesDRThe role of sleep-disordered breathing, daytime sleepiness, and impaired performance in motor vehicle crashes – a case control studySleep Breath200482617215211390
  • LindbergECarterNGislasonTJansonCRole of snoring and daytime sleepiness in occupational accidentsAm J Respir Crit Care Med2001164112031203511739131
  • DauvilliersYAPaquereauJBastujiHDronotXWeilJJViot-BlancVPsychological health in central hypersomnia: The French Harmony StudyJ Neurol Neurosurg Psychiatry200980663664119211597
  • MulgrewATRyanCFFleethamJAThe impact of obstructive sleep apnea and daytime sleepiness on work limitationSleep Med200791425317825611
  • PucaFMPerrucciSPrudenzanoMPQuality of life in shift work syndromeFunct Neurol19961152612689119269
  • SforzaEJanssensJPRochatTIbanezVDeterminants of altered quality of life in patients with sleep-related breathing disordersEur Respir J200321468268712762357
  • KeamSWalkerMCTherapies for narcolepsy with or without cataplexy: evidence-based reviewCurr Opin Neurol200720669970317992092
  • SchwartzJRLRothTShift work sleep disorder. Burden of illness and approaches to managementDrugs200666182357237017181377
  • SmithIEQuinnellTGPharmacotherapies for obstructive sleep apnoea. Where are we now?Drugs200464131385139915212557
  • HauckWAdamPBobierCLandmesserNUse of large-scale chromatography in the preparation of armodafinilChirality200820889689918506833
  • KrakowBMelendrezDFerreiraEPrevalence of insomnia symptoms in patients with sleep-disordered breathingChest200112061923192911742923
  • HirshkowitzMThe clinical consequences of obstructive sleep apnea and associated excessive sleepinessJ Fam Pract200857SupplS9S1618687238
  • JohnsMWA new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleep19911465405451798888
  • HardingeFMPitsonDJStradlingJRUse of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoeaRespir Med19958996176207494915
  • JohnsMWSensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth Sleepiness Scale: failure of the MSLT as a gold standardJ Sleep Res20009151110733683
  • HeatonKAndersonDA psychometric analysis of the Epworth Sleepiness ScaleJ Nurs Meas200715317718818232617
  • WeaverTEMaislinGDingesDFRelationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioningSleep200730671171917580592
  • DarkeSKayeSMcKetinRDuflouJMajor physical and psychological harms of methamphetamine useDrug Alcohol Rev200827325326218368606
  • RobertsonPJrHellriegelETClinical pharmacokinetic profile of modafinilClin Pharmacokinet200342212313712537513
  • WongYNKingSPSimcoeDOpen-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjectsJ Clin Pharmacol199939328128810073328
  • WongYNSimcoeDHartmanLNA double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteersJ Clin Pharmacol199939130409987698
  • Food and Drug AdministrationFDA-approved Labeling Text for NDA 21-875/NUVIGIL (armodafinil) Tablets2007 URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021875lbl.pdfAccessed June 30, 2009
  • WisorJPDementWCAimoneLWilliamsMBozyczko-CoyneDArmodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the ratPharmacol Biochem Behav200685349249917134745
  • BeckPOdleAWallace-HuittTSkinnerRDGarcia-RillEModafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonistsSleep200831121647165419090320
  • RaoYLiuZWBorokEProlonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neuronsJ Clin Invest2007117124022403318060037
  • MitchellHABogenpohlJWLilesLCBehavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic–dopaminergic mechanism of actionPharmacol Biochem Behav200891221722218703079
  • QuWMHuangZLXuXHMatsumotoNUradeYDopaminergic D1 and D2 receptors are essential for the arousal effect of modafinilJ Neurosci200828348462846918716204
  • MignotENishinoSGuilleminaultCDementWCModafinil binds to the dopamine uptake carrier site with low affinitySleep19941754364377991954
  • VolkowNDFowlerJSLoganJEffects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implicationsJAMA2009301111148115419293415
  • DarwishMKirbyMHellriegelETYangRRobertsonPJrPharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studiesClin Drug Investig200929287100
  • DarwishMKirbyMRobertsonPJrHellriegelETInteraction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjectsClin Pharmacokinet2008471617418076219
  • YoungTPaltaMDempseyJSkatrudJWeberSBadrSThe occurrence of sleep-disordered breathing among middle-aged adultsN Engl J Med199332817123012358464434
  • RothTWhiteDSchmidt-NowaraWEffects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adultsClin Ther200628568970616861091
  • HirshkowitzMBlackJEWesnesKNieblerGAroraSRothTAdjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndromeRespir Med2007101361662716908126
  • HullSLankfordAVinceBNieblerGEAroraSArmodafinil improves fatigue in patients with excessive sleepiness due to obstructive sleep apnea/hypopnea syndromeAmerican Psychiatric Association Annual MeetingToronto, CanadaMay 25, 2006 [Abstract No. 127]
  • RothTRipponGAAroraSArmodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apneaSleep Breath2008121536217874255
  • RothTCzeislerCAWalshJKRandomized, double-blind, placebo-controlled study of armodafinil for the treatment of excessive sleepiness associated with chronic shift work sleep disorderNeuropsychopharmacology200530SupplS140 [Abstract No. 161]
  • CzeislerCAWalshJKWesnesKAAroraSARothTArmodafinil for the treatment of excessive sleepiness associated with shiftwork disorder: A randomized controlled studyMayo Clinic Proceedings2009841195897219880686
  • HarshJRHaydakRRosenbergRThe efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsyCurr Med Res Opin200622476177416684437
  • McMenaminTMA time to work: recent trends in shift work and flexible schedulesMonthly Labor Review122007315 URL: http://www.bls.gov/opub/mlr/2007/12/art1full.pdfAccessed April 2, 2009
  • AkerstedtTShift work and disturbed sleep/wakefulnessOccup Med (Lond)2003532899412637592
  • BoggildHKnutssonAShift work, risk factors and cardiovascular diseaseScand J Work Environ Health1999252859910360463
  • KnutssonAHealth disorders of shift workersOccup Med (Lond)200353210310812637594
  • CzeislerCAWalshJKWesnesKAAroraSARothTArmodafinil for the treatment of excessive sleepiness associated with shiftwork disorder: A randomized controlled studyMayo Clinic Proceedings2009841195897219880686
  • LongstrethWTJrTonTGKoepsellTGersukVHHendricksonAVeldeSPrevalence of narcolepsy in King County, Washington, USASleep Med200910442242619013100
  • MignotESleep, sleep disorders and hypocretin (orexin)Sleep Med20045Suppl 1S2S815301991
  • BlackJHullSGTillerJYangRHarshJRMaintenance of efficacy, safety and tolerability of armodafinil: An open-label extension study [Abstract 0419]Sleep200932SupplA139
  • SchwartzJRKhanAMcCallVWeintraubJTillerJA 12 month or more open-label study of the efficacy and tolerability of armodafinil [Abstract 0148]Sleep200932SupplA50A51
  • BoganRTillerJYangRYouakimJRothTArmodafinil for excessive sleepiness associated with jet lag disorder [Abstract 0153]Sleep200932SupplA52